Q66F11 AF NFT

Valine--tRNA ligase

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeiceucc54eruxlssqcuegdyoxjasmo2oessklvaibbmeldtgrpz7fe/metadata.json
IPFS of structure file: 
bafybeifqja7vwifzui5lc5w4dhfmhqrjqjkwuu6fjycqxaumfmkqjyfk5e/AF-Q66F11-F1-model_v2.pdb
First NFT owner address (eip-55): 
0x8B68258Ca46852D03B69a12F533693A548Bb3f7A
First NFT owner address (bech32): 
genesis13d5ztr9ydpfdqwmf5yh4xd5n54ytk0m6urj3k0
Current NFT ID #455151 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1_w

NFT id:
455151
Accession (UniProt):
Q66F11
Name::
Valine--tRNA ligase
Experimental Method:
Predicted structure
Sequence source:
YERSINIA PSEUDOTUBERCULOSIS SEROTYPE I (STRAIN IP32953)

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT Q66F11 research and analysis (ICN3D with VR)

FASTA sequences

>sp|Q66F11|SYV_YERPS Valine--tRNA ligase OS=Yersinia pseudotuberculosis serotype I (strain IP32953) OX=273123 GN=valS PE=3 SV=1 MENTPSHINKTEPSLDKTYSPQEIEQPLYEHWEKQGYFKPNGDTSKESYCIMIPPPNVTGSLHMGHAFQQTIMDTLIRYQRMQGKNTLWQAGTDHAGIATQMVVERKIAAEEGKTRHDYGRDAFIDKIWEWKGESGGTITRQMRRLGNSVDWERERFTMDEGLSNAVKEVFVRLHKEDLIYRGKRLVNWDPKLRTAISDLEVENRESKGSMWHLRYPLADGAKTAEGKDYLVVATTRPETVLGDTGVAVNPEDPRYKDLIGKEVILPLVGRRIPILGDEHADMEKGTGCVKITPAHDFNDYEVGKRHALPMINILTFDGDIRSEAEVFDTHGEATDAFSNAIPAQFQGLERFAARKAVVAEFEKLGLLEEVKPHDLTVPYGDRGGVVIEPMLTDQWYVRTAPLAKVAIEAVENGEIQFVPKQYENMYYSWMRDIQDWCISRQLWWGHRIPAWYDEQGNVYVGRDEAEVRRDNNLGAEVALRQDEDVLDTWFSSGLWTFSTLGWPEQTDALKTFHPTSVVVSGFDIIFFWIARMIMLTMHFMKDENGKPQVPFKTVYMTGLIRDDEGQKMSKSKGNVIDPLDMVDGISLEALLEKRTGNMMQPQLAEKIRKRTEKQFPNGIEPHGTDALRFTLAALASTGRDINWDMKRLEGYRNFCNKLWNASRFVLMNTEGQDCGQNGGEMVLSLADRWILAEFNQTIKAYREAMDTYRFDLAAGILYEFTWNQFCDWYLELTKPVMNSGSEAELRGTRHTLIQVLEALLRLAHPIIPYITETIWQRVKNLKGITADTIMLQPFPEYDASQVDEQALSDLEWIKQTIIAVRNIRAEMNIAPGKPLEVMLRGANAQAQRRVLENQSFIQSLARLSSLTLLAEGDKGPVSVTKLVEGAEVLIPMAGLIDKATELDRLAKEVAKLDAEIERIEGKLGNEGFVARAPEAVVAKERERLAACAEAKQKLIEQQATIAAL